From its state-of-the-art diagnostic laboratory to its Internet-based PATHSiTE®, Clarient delivers advanced oncology diagnostic services to pathologists, oncologists, hospitals and biopharmaceutical companies throughout the U.S. Clarient also is developing proprietary companion diagnostic tests for therapeutics in breast, prostate, lung and colon cancers, as well as leukemia/lymphoma.
Clarient is improving the lives of those affected by cancer by bringing clarity to a complex disease. For more information visit http://www.clarient.com/.
Ad Statistics
Times Displayed: 22345
Times Visited: 450 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
1 World Health Organization. www.who.int/mediacentre/factsheets/fs297/en/. Accessed November 2014.
2 Hamady ZZ, et al. Surgical pathological second opinion in thyroid malignancy: impact on patients’ management and prognosis. Eur J Surg Oncol. 2005 Feb;31(1):74-7.
3 Coblentz TR, et al. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma. Cancer. 2001 Apr 1;91(7):1284-90.
4 Staradub VL, et al. Changes in breast cancer therapy because of pathology second opinions. Ann Surg Oncol. 2002 Dec;9(10):982-7.
5 Nguyen PL, et al. The impact of pathology review on treatment recommendations for patients with adenocarcinoma of the prostate. Urol Oncol. 2004 Jul-Aug;22(4):295-9.
6 www.who.int/mediacentre/factsheets/fs297/en/. Accessed July 2014
7 Elmore JG et al. Diagnostic Concordance Among Pathologists Interpreting Breast Biopsies Specimen. JAMA. Published 17 March 2015.
8 Newman EA, Guest AB, Helvie MA, et al. Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer. 2006;107:2346–2351.
9 Romanoff, et al. Breast Pathology Review: Does It Make a Difference? Annals of Surgical Oncology. Published 24 May 2014.
Back to HCB News
